Form 4: AtriCure CEO Michael Carrel Reports Gift of Shares to Children
SEC Form 4 Filing
AtriCure's CEO, Michael Carrel, reported a gift of 4,000 common stock shares to his children on March 10, 2025, according to a Form 4 filing with the SEC.
Summary
- On March 10, 2025, Michael H. Carrel, the President, CEO, and Director of AtriCure, Inc. (ATRC), gifted 4,000 shares of common stock to his children.
- The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.
- Following the transaction, Carrel directly owns 706,555 shares of AtriCure common stock.
- Carrel also indirectly owns 9,310 shares held by his children and 2,250 shares held by his parents, but disclaims beneficial ownership except for his pecuniary interest.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing regarding a stock gift. It doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
This is a routine disclosure of insider transactions, required by the SEC to ensure transparency and prevent insider trading. It's common for executives to gift shares for estate planning or other personal reasons.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it's a personal transaction by the CEO and doesn't affect the company's operations or financial position.
Key Dates
| Date | Description |
|---|---|
| 03/10/2025 | Date of the stock gift transaction |
| 03/12/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.